Rocket


News + Filings
Transactions





Tate Simon

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
05/19/2022Eliem Therapeutics, Inc.ELYMGrantStock Option (Right To Buy)10k$3.46$34.6k 05/19/2022
08/09/2021Eliem Therapeutics, Inc.ELYMGrantStock Option (Right to Buy)20k$12.50$250k 08/09/2021

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy